Influence of MAb (F(Ab)2 OC 125 on the survival rate of ovarian carcinoma patients.
Nesselhut
T
T
Institute for Tumorimmunology, Duderstadt, Germany.
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D007457:Iodine Radioisotopes; D016555:Matched-Pair Analysis; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging* / Q000276:immunology / Q000401:mortality; D016719:Radioimmunodetection; D015996:Survival Rate
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D007140:Immunoglobulin Fab Fragments; D007457:Iodine Radioisotopes